An activist’s guide to rifapentine-based TB prevention (2024)
4 June 2024. Related: TB coinfection, Other news, On the web.
TAG, New York
The new 2024 update of An activist’s guide to rifapentine TB preventive treatment: 3HP and 1HP lays out what TB community advocates need to know about rifapentine-based TPT.
The publication explains the strong evidence behind these regimens, including newly published research demonstrating that 3HP is safe and effective taken concurrently from Day 1 of dolutegravir-based ART.
Readers will also learn who would benefit from TPT and why, how to push back against common excuses for not scaling up TPT, and how to strategize around drug availability and build demand for 1HP and 3HP in TB-affected communities.
TAG. An activist’s guide to rifapentine TB preventive treatment: 3HP and 1H (2024)
https://www.treatmentactiongroup.org/wp-content/uploads/2024/05/rifapentine_guide_2024_final.pdf (PDF)